SCHEMBL5626548

SCHEMBL5626548

FC(F)=C(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)=C(F)F

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29700985 1.00 THRB (0.35) THRB
SCHEMBL8461054 0.96 THRB (0.30) THRB
SCHEMBL15352138 0.91 THRB (0.31) THRB
SCHEMBL157953 0.91 THRB (0.48) THRB
SCHEMBL161264 0.91 THRB (0.48) THRB
SCHEMBL633063 0.91 THRB (0.48) THRB
SCHEMBL15352690 0.91 THRB (0.31) THRB
SCHEMBL6664831 0.91 THRB (0.48) THRB
SCHEMBL161271 0.91 THRB (0.48) THRB
SCHEMBL1033285 0.91 THRB (0.48) THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732937-A1 COMPOUND FOR OPTICAL MATERIALS AND METHODS OF FABRICATION General Electric Company (US) 2006-12-20 EP claimed
WO-2005097843-A1 COMPOUND FOR OPTICAL MATERIALS AND METHODS OF FABRICATION GENERAL ELECTRIC COMPANY (US) 2005-10-20 WO claimed
US-20050214479-A1 Compound for optical materials and methods of fabrication MOMENTIVE PERFORMANCE MATERIALS INC. 2005-09-29 US claimed
EP-4253432-B1 FLUOROPOLYMER, AQUEOUS LIQUID DISPERSION, COMPOSITION, AND CROSSLINKED PRODUCT DAIKIN IND LTD (JP) 2026-02-25 EP disclosed
EP-4253432-A1 FLUOROPOLYMER, AQUEOUS LIQUID DISPERSION, COMPOSITION, AND CROSSLINKED PRODUCT DAIKIN INDUSTRIES, LTD. (JP) 2023-10-04 EP disclosed
US-20230303748-A1 FLUOROPOLYMER, AQUEOUS LIQUID DISPERSION, COMPOSITION, AND CROSSLINKED PRODUCT DAIKIN INDUSTRIES, LTD. (JP) 2023-09-28 US disclosed
WO-2022114012-A1 FLUOROPOLYMER, AQUEOUS LIQUID DISPERSION, COMPOSITION, AND CROSSLINKED PRODUCT ダイキン工業株式会社 2022-06-02 WO disclosed
US-7214475-B2 Partially polymerizing a blend of a bis(trifluorovinyl) derivative of a group of a group 14 metal (especially Si or Ge) compound, another bis(trifluorovinyl) compound, a photocurable compound and a photoinitiator; depositing product on a substrate; exposing to effect photocuring; and curing the product MOMENTIVE PERFORMANCE MATERIALS INC. 2007-05-08 US disclosed
US-7214475-B2 Partially polymerizing a blend of a bis(trifluorovinyl) derivative of a group of a group 14 metal (especially Si or Ge) compound, another bis(trifluorovinyl) compound, a photocurable compound and a photoinitiator; depositing product on a substrate; exposing to effect photocuring; and curing the product MOMENTIVE PERFORMANCE MATERIALS INC. 2007-05-08 US disclosed
EP-1732937-A1 COMPOUND FOR OPTICAL MATERIALS AND METHODS OF FABRICATION General Electric Company (US) 2006-12-20 EP disclosed
WO-2005097843-A1 COMPOUND FOR OPTICAL MATERIALS AND METHODS OF FABRICATION GENERAL ELECTRIC COMPANY (US) 2005-10-20 WO disclosed
US-20050214479-A1 Compound for optical materials and methods of fabrication MOMENTIVE PERFORMANCE MATERIALS INC. 2005-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050214479-A1 Compound for optical materials and methods of fabrication AFF2, AFF1, ELOVL6 THRB 2290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.